Molecular homology and the luminal transport of Hg2+ in the renal proximal tubule.
The aim of this study was to define mechanisms involved in the luminal uptake of inorganic mercury in the kidney using isolated perfused straight (S2) segments of the proximal tubule. When mercuric conjugates of glutathione (GSH), cysteinylglycine. or cysteine (containing 203Hg2+) were perfused through the lumen, the rates of luminal disappearance flux (JD) of inorganic mercury were approximately 39, 53, and 102 fmol/min per' min, respectively. Thus, the rates of luminal uptake of mercury are greater when the mercury is in the form of a mercuric conjugate of cysteine than in the form of a mercuric conjugate of cysteinylglycine or GSH. Addition of acivicin to the perfusate, to inhibit activity of the y-glutamyltransferase, caused significant reductions in the J,, for mercury in tubules perfused with mercuric conjugates of GSH. Addition of cilastatin, an inhibitor of dehydropeptidase- l (cysteinylglycinase) activity, caused significant reductions in the uptake of mercury in tubules perfused with mercuric conjugates of cysteinylglycine. These findings indicate that a significant amount of the luminal uptake of mercury, when mercuric conjugates of GSH are present in the lumen, is dependent on the activity of both y-glutamyltransferase and cysteinylglycinase. Finally, the JD for mercury in tubules perfused with mercuric conjugates of cysteine was reduced by approximately 50% when 3.0 mM L-lysine or 5.0 mM cycloleucine was added to the perfusate. It is concluded that these findings indicate that at least some of the luminal uptake of mercuric conjugates of cysteine occurs at the site of one or more amino acid transporters via a mechanism involving molecular homology.
Cannon
Vernon T
VT
Department of Biology, Georgia State University, Atlanta, Georgia.
Barfuss
Delon W
DW
Department of Biology, Georgia State University, Atlanta, Georgia.
Zalups
Rudolfs K
RK
Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, Georgia.
D000818:Animals; D015377:Cilastatin / Q000494:pharmacology; D003545:Cysteine / Q000502:physiology; D004150:Dipeptidases / Q000037:antagonists & inhibitors / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005978:Glutathione / Q000493:pharmacokinetics; D066298:In Vitro Techniques; D007555:Isoxazoles / Q000494:pharmacology; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000378:metabolism*; D008628:Mercury / Q000493:pharmacokinetics*; D011480:Protease Inhibitors / Q000494:pharmacology; D011817:Rabbits; D017386:Sequence Homology, Amino Acid; D005723:gamma-Glutamyltransferase / Q000037:antagonists & inhibitors / Q000502:physiology
D004791:Enzyme Inhibitors; D007555:Isoxazoles; D011480:Protease Inhibitors; D015377:Cilastatin; D005723:gamma-Glutamyltransferase; C019974:cysteinyl-glycine dipeptidase; D004150:Dipeptidases; D008628:Mercury; D005978:Glutathione; D003545:Cysteine; C006303:acivicin